Albemarle Corporation

ALB Basic Materials Specialty Chemicals

Albemarle Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, down 4.37% from fiscal 2024.

Revenue
+18.8%
EPS
+225.6%
Free cash flow
+708.4%
Total debt
−48.1%

Quarter to September 2026, against a year earlier

100.60 2.23 +2.27%
Market cap
$11.6B
P/E
22.6×
Fwd P/E
9.9×
Dividend yield
1.65%
F-score
6/9
Altman Z
2.31
Beneish M
−3.71
Dividend safety
47/100

Albemarle Corporation 10-Q filed May 6, 2026

Fiscal Q1 2026 · Period ended Mar 31, 2026 · Filed · accepted 4:34 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed Nov 5, 2025: 17 added · 80 removed · 65 modified; 16 with only figures updated; 2 moved without change

  1. Added

    The following discussion should be read together with the consolidated financial statements and related notes included in Albemarle Corporation’s (“Albemarle,” “we,” “us,” “our” or the “Company”) Annual Report on Form 10-K for the fiscal year ended December 31, 2025, and the condensed consolidated financial statements and related notes included in this Quarterly Report on Form 10-Q. The following discussion contains forward-looking statements. For a discussion of limitations inherent in such statements, please see “Forward-Looking Statements.”